open access

Vol 69, No 1 (2018)
Original article
Published online: 2018-03-28
Submitted: 2018-01-05
Accepted: 2018-02-23
Get Citation

Prevalence of chronic obstructive respiratory diseases amongst fishermen

Omar Laraqui, Reda Hammouda, Salwa Laraqui, Nadia Manar, Tarik Ghailan, Jaouda Ben Amor, Frédéric Deschamps, Chakib El Houssine Laraqui
DOI: 10.5603/IMH.2018.0003
·
Pubmed: 29611609
·
International Maritime Health 2018;69(1):13-21.

open access

Vol 69, No 1 (2018)
MARITIME MEDICINE Original articles
Published online: 2018-03-28
Submitted: 2018-01-05
Accepted: 2018-02-23

Abstract

Background: The objective was to screen and evaluate the prevalence of respiratory diseases and obstructive  ventilatory defects among fishermen in Morocco. 

Materials and methods: This observational and cross-sectional epidemiological study involved 924 men  over 20 years old and with at least two years of seniority. It included a questionnaire and a spirometry.  The questionnaire is composed of four sections: sociodemographic and occupational characteristics, toxic  habits, medical history and respiratory clinical symptoms. 

Results: The prevalence of symptoms of tracheobronchial irritation was 9.2% for cough, 8.2% for sputum  7.8% for dyspnoea and chest wheezing 8.1%. The frequency of rhinitis was 17.1%, asthma 6.8%, chronic  bronchitis 5.6% and chronic obstructive pulmonary disease (COPD) 4.1% (5.4% for current and former  smokers versus 1.1% for non-smokers). The prevalence was reaching 6.8% among those who smoked  more than 10 pack-years and 17.9% among those who smoked more than 20 pack-years. Among subjects  over 40 years old who had smoked more than 10 pack-years, the prevalence of COPD was 8.1%. The  comorbidities were frequent. 

Conclusions: Smoking was very common among fishermen. Symptoms and respiratory diseases remain  underdiagnosed and undertreated. Prevention and early detection must be a priority in this sector. 

Abstract

Background: The objective was to screen and evaluate the prevalence of respiratory diseases and obstructive  ventilatory defects among fishermen in Morocco. 

Materials and methods: This observational and cross-sectional epidemiological study involved 924 men  over 20 years old and with at least two years of seniority. It included a questionnaire and a spirometry.  The questionnaire is composed of four sections: sociodemographic and occupational characteristics, toxic  habits, medical history and respiratory clinical symptoms. 

Results: The prevalence of symptoms of tracheobronchial irritation was 9.2% for cough, 8.2% for sputum  7.8% for dyspnoea and chest wheezing 8.1%. The frequency of rhinitis was 17.1%, asthma 6.8%, chronic  bronchitis 5.6% and chronic obstructive pulmonary disease (COPD) 4.1% (5.4% for current and former  smokers versus 1.1% for non-smokers). The prevalence was reaching 6.8% among those who smoked  more than 10 pack-years and 17.9% among those who smoked more than 20 pack-years. Among subjects  over 40 years old who had smoked more than 10 pack-years, the prevalence of COPD was 8.1%. The  comorbidities were frequent. 

Conclusions: Smoking was very common among fishermen. Symptoms and respiratory diseases remain  underdiagnosed and undertreated. Prevention and early detection must be a priority in this sector. 

Get Citation

Keywords

fishermen, chronic pulmonary diseases, Morocco

About this article
Title

Prevalence of chronic obstructive respiratory diseases amongst fishermen

Journal

International Maritime Health

Issue

Vol 69, No 1 (2018)

Article type

Original article

Pages

13-21

Published online

2018-03-28

DOI

10.5603/IMH.2018.0003

Pubmed

29611609

Bibliographic record

International Maritime Health 2018;69(1):13-21.

Keywords

fishermen
chronic pulmonary diseases
Morocco

Authors

Omar Laraqui
Reda Hammouda
Salwa Laraqui
Nadia Manar
Tarik Ghailan
Jaouda Ben Amor
Frédéric Deschamps
Chakib El Houssine Laraqui

References (35)
  1. Société Pneumologique de Langue Française. Recommandations de la Société de Pneumologie de Langue Française sur la prise en charge de la BPCO (mise à jour 2009). Rev Mal Resp. 2010; 27(5): 522–548.
  2. Ameille J, Dalphin JC, Descatha A, et al. La broncho-pneumopathie chronique obstructive professionnelle : une maladie méconnue. Revue mal resp. 2006; 23(supl 4): 119–30.
  3. Delmas MC, Fuhrman C. L’asthme en France : synthèse des données épidémiologiques descriptives. Rev Mal Resp. 2010; 27(2): 151–159.
  4. Fuhrman C, Delmas MC. Épidémiologie descriptive de la bronchopneumopathie chronique obstructive (BPCO) en France. Rev Mal Resp. 2010; 27(2): 160–168.
  5. Khelafi R, Aissanou A, Tarsift S, et al. Épidémiologie de la bronchopneumopathie chronique obstructive dans la wilaya d’Alger. Rev Mal Resp. 2011; 28(1): 32–40.
  6. Idrees M, Koniski ML, Taright S, et al. BREATHE Study Group. Management of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012; 106 Suppl 2: S33–S44.
  7. Uzaslan E, Mahboub B, Beji M, et al. BREATHE Study Group. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012; 106 Suppl 2: S45–S59.
  8. Burrows B, Knudson RJ, Cline MG, et al. Quantitative relationships between cigarette smoking and ventilatory function. Quantitative relationships between smoking cigarette and ventilatory function Am Rev Respir Dis. 1977; 115(2): 195–205.
  9. Stang P, Lydick E, Silberman C, et al. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest. 2000; 117(5 Suppl 2): 354S–359S.
  10. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003; 97(2): 115–122.
  11. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010; 65(1): 14–20.
  12. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009; 18(114): 213–221.
  13. Jalal T, El Omari F, Sabir M. Rapport annuel de l’Observatoire national des drogues et addictions. Maroc, Rapport officiel 2014:108. www.onda-drogues.com (2014).
  14. Tessier JF, Nejjari C. Bennani Othmani M. Epidémiologie du tabagisme dans les pays de la méditerranée. Int J Tuberc Lung Dis. 1999; 3(10): 927–937.
  15. Laraqui O, Laraqui S, Manar N, et al. Risk-taking behaviours among fishermen in Morocco by the evaluation of. Int Marit Health. 2017; 68(2): 83–89.
  16. Laraqui O, Laraqui S, Manar N, et al. Prevalence of consumption of addictive substances amongst Moroccan fishermen. Int Marit Health. 2017; 68(1): 19–25.
  17. Kauffmann F, Annesi-Maesano I, Liard R, et al. Construction et validation d’un questionnaire en épidémiologie respiratoire. Rev Mal Respir. 2002; 19(3): 323–333.
  18. Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. 1987--updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J. 1989; 2(2): 165–177.
  19. MRC committee on the aetiology of chronic bronchitis. Standardised questionnaires on respiratory symptoms. Br Med J. 1960; 2: 16–65.
  20. American Lung Association Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis. 1978; 6: 7–53.
  21. Osterman JW, Armstrong BG, Ledoux E, et al. Comparison of French and English versions of the American Thoracic Society respiratory questionnaire in a bilingual working population. Int J Epidemiol. 1991; 20(1): 138–143.
  22. Sadoul P. Evaluation du déficit fonctionnel et respiratoire. Bull Eur Physiopath Respir. 1983; 19: 3–6.
  23. Pocket guide to COPD diagnosis, management, and prevention. Global Initiative for chronic obstructive lung disease, 2017 report. http://goldcopd.org/pocket-guide-copd-diagnosis-management-prevention-2016/.
  24. El Rhazi K, Nejjari C, Berraho M, et al. Inequalities in smoking profiles in Morocco: the role of educational level. Int J Tuberc Lung Dis. 2008; 12(11): 1327–1332.
  25. Goullé JP, Morel F. Addictions en milieu professionnel. Académie nationale de médecine, Paris. http://www.academie-medecine.frarticles-du-bulletinpublicationidpublication=100768 (Rapport 10 october 2017).
  26. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28(3): 523–532.
  27. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2005; 366: 1875–81.
  28. Lange P, Celli B, Agustí A, et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med. 2015; 373(2): 111–122.
  29. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet. 2007; 370(9589): 758–764.
  30. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis. 1992; 145(2 Pt 1): 301–310.
  31. Eisner MD, Anthonisen N, Coultas D, et al. Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182(5): 693–718.
  32. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009; 374(9691): 733–743.
  33. Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011; 378(9795): 991–996.
  34. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am j respir crit med. 2003; 167: 782–92.
  35. Blanc PD, Iribarren C, Trupin L, et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax. 2009; 64(1): 6–12.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl